Donar ahora Conviértase en Miembro

Carrito (0)

Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Capital Hilton

28 oct 2024 8:30 a.m. - 30 oct 2024 12:40 p.m.

1001 16th Street NW, Washington, DC 20036-5794

DIA/FDA Oligonucleotide-Based Therapeutics Conference

CONTACT US

Send Email 1.888.257.6457

CONTACT US

Send Email 1.888.257.6457

Agenda

Día 1 28 oct 2024

11:00 AM — 12:30 PM

Session 2 Track 3: Regulatory Experiences with Clinical/ Commercial Oligonucleotides

1:30 PM — 3:00 PM

Session 3 Track 3: Emerging Oligonucleotide CMC Guidance

3:30 PM — 4:45 PM

Session 4 Track 3: Demonstrating Comparability for Oligonucleotides Therapeutics

Día 2 29 oct 2024

10:00 AM — 11:30 AM

Session 6 Track 3: CMC Considerations in Development of mRNA-based Therapeutics

12:45 PM — 2:15 PM

Session 7 Track 3: Challenges Around Oligonucleotides Control Strategies

Día 3 30 oct 2024

8:00 AM — 9:15 AM

Session 9 Track 3: Innovative Manufacturing Approaches and Regulatory Implications

9:25 AM — 10:40 AM

Session 10 Track 3: Streamlining Oligonucleotide Development with Platform Approaches Roundtable

¿Tiene una cuenta?